Nondetectable prostate-specific antigen in moderately differentiated adenocarcinoma of prostate.

Autor: Daugherty RL; Department of Urology, University of Rochester School of Medicine and Dentistry, New York., Cos LR, Keller JW, di Sant'Agnese A
Jazyk: angličtina
Zdroj: Urology [Urology] 1992 Jun; Vol. 39 (6), pp. 552-5.
DOI: 10.1016/0090-4295(92)90016-p
Abstrakt: Prostate-specific antigen (PSA) is a glycoprotein derived from prostatic ductal and acinar epithelial cells. The main clinical use of PSA is as a marker of prostate tumor progression/recurrence. We present a case of a sixty-nine-year-old patient with recurrent endometrioid carcinoma of the prostate (status post-radical prostatectomy, hormonal therapy, and external beam radiation therapy) with normal serum PSA.
Databáze: MEDLINE